MetaCure (USA) Inc. (MetaCure) is a medical device company developing minimally invasive solutions for the treatment of type 2 diabetes and obesity. The company has developed a proprietary technology named Gastric Contractility Modulation (GCM). MetaCure`s flag ship product is the TANTALUS System, which The system uses implantable electrodes to sense and monitor the natural activity of the stomach automatically applies a gentle electrical stimulation during meals.
. The TANTALUS System is designed to sense naturally occurring electrical activity of the stomach in real-time and applies electrical stimulation treatment during the meal. The TANTALUS pulse generator is implanted through a minimally invasive laparoscopic procedure. MetaCure is located at Orangeburg in New York, the US.